Edward Terrien, MD
Cardiovascular Disease · Loris, SCNPI 1013928910
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $41,681 of the $49,834 with a category attached, or 83.6%. Medtronic accounts for 88.9% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2019 at $20,570 and has fallen 98.6% since, to $291 in 2025. Among cardiovascular disease clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 102 payments — averaging $488.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$44K
- Penumbra, Inc.$2K
- Boston Scientific$1K
- Abbott$425
- Inari Medical, Inc.$294
- Shockwave Medical, Inc$269
- plus $750 from 15 others
What the payments were for
- Speaking & faculty fees$41,68184%
- Travel & lodging$5,10210%
- Food & beverage$3,0376%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 54 | $44,316 |
| Penumbra, Inc. | 1 | $2,400 |
| Boston Scientific | 12 | $1,381 |
| Abbott | 6 | $425 |
| Inari Medical, Inc. | 6 | $294 |
| Shockwave Medical, Inc | 3 | $269 |
| Abiomed | 3 | $207 |
| Heartflow, Inc. | 1 | $90 |
| Lantheus Medical Imaging, Inc. | 1 | $87 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $87 |
| AstraZeneca | 3 | $85 |
| Pfizer | 2 | $42 |
| Recor Medical Inc | 1 | $23 |
| Cardiva Medical, Inc. | 1 | $20 |
| Merck | 1 | $19 |
| Edwards Lifesciences | 1 | $17 |
| Amgen | 1 | $17 |
| Solventum Corporation | 1 | $17 |
| Veryan Medical Incorporated | 1 | $15 |
| Cardiovascular Systems Inc. | 1 | $13 |
| Novartis | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$49,834 in reported general payments places this provider in the 95th percentile of 257 cardiovascular disease providers in South Carolina.
See all cardiovascular disease providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 47 | $65,983 |
| Repatha SureclickEvolocumab | 11 | $11,582 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 21 | $667 |
| Metoprolol Succinate | 60 | $633 |
| Famotidine | 51 | $613 |
| Losartan Potassium | 35 | $445 |
| ClopidogrelClopidogrel Bisulfate | 40 | $335 |
| Atorvastatin Calcium | 35 | $291 |
| Carvedilol | 20 | $164 |
| Pantoprazole Sodium | 22 | $120 |
| Amlodipine Besylate | 18 | $115 |
| Metoprolol Tartrate | 18 | $91 |
| Nitroglycerin | 11 | $78 |
| Spironolactone | 17 | $70 |
| Furosemide | 14 | $68 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $42 | $65,98347 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 257 cardiovascular disease providers in South Carolina.
Other cardiovascular disease in Loris
- Robert BiedermanCharleston$775K
- Darren SidneyNorth Charleston$129K
- Priyanka BhattacharyaCharleston$107K
- Gregory SanGreenville$88K
- David McNeelyGreenville$78K
- Gregory EavesAiken$65K
- James SmithCharleston$64K
- Christopher SalmonGreenville$54K
- Ricky HendersonAnderson$52K
- Geetha PintoCharleston$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.